Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Guangxi Wuzhou Zhongheng Group Co Days Payable?
Guangxi Wuzhou Zhongheng Group CoSHSE:600252 -4.87%39 Days Payable is 218.49 as of Mar. 2026, which is 18% above its 10-year median of 185.25. GuruFocus rates SHSE:600252 with a GF Score™ of 39/100 and a GF Value™ of ¥1.57 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 927 Drug Manufacturers companies, Guangxi Wuzhou Zhongheng Group Co ranks better than 85.01% on this metric.
The historical rank and industry rank for Guangxi Wuzhou Zhongheng Group Co's Days Payable or its related term are showing as below:
SHSE:600252'
s Days Payable Range Over the Past 10 Years
Min: 36.1 Med: 185.25 Max: 530.7
Current: 205.45
During the past 13 years, Guangxi Wuzhou Zhongheng Group Co's highest Days Payable was 530.70. The lowest was 36.10. And the median was 185.25.
SHSE:600252's Days Payable is ranked better than 85.01% of 927
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs SHSE:600252: 205.45
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangxi Wuzhou Zhongheng Group Co Days Payable Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Guangxi Wuzhou Zhongheng Group Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangxi Wuzhou Zhongheng Group Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Guangxi Wuzhou Zhongheng Group Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Guangxi Wuzhou Zhongheng Group Co's Days Payable falls into.
Guangxi Wuzhou Zhongheng Group Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guangxi Wuzhou Zhongheng Group Co (SHSE:600252) has a Days Payable of 218.49 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Guangxi Wuzhou Zhongheng Group Co and its competitors. This is 18% above median its historical median of 185.25. Over the past decade, Guangxi Wuzhou Zhongheng Group Co's Days Payable has ranged from 36.10 to 530.70. According to the industry distribution chart, Guangxi Wuzhou Zhongheng Group Co ranks #139 out of 927 companies in the Drug Manufacturers industry, placing it in the top 15%.
Is Guangxi Wuzhou Zhongheng Group Co's Days Payable too high?
Guangxi Wuzhou Zhongheng Group Co's current Days Payable of 218.49 is 18% above median its 10-year median of 185.25. Over the past 10 years, this metric has ranged from a low of 36.10 to a high of 530.70. The Drug Manufacturers industry median Days Payable is 90.38. Guangxi Wuzhou Zhongheng Group Co's value of 218.49 is 141.7% above this industry median. Based on the distribution chart, Guangxi Wuzhou Zhongheng Group Co ranks #139 out of 927 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Guangxi Wuzhou Zhongheng Group Co has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Guangxi Wuzhou Zhongheng Group Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Guangxi Wuzhou Zhongheng Group Co ranks #139 out of 927 companies for Days Payable. This places Guangxi Wuzhou Zhongheng Group Co in the top 15% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.38. Guangxi Wuzhou Zhongheng Group Co's value of 218.49 is 141.7% above this benchmark. Historically, Guangxi Wuzhou Zhongheng Group Co's own Days Payable has ranged from 36.10 to 530.70 over the past decade. While the company's 10-year median is 185.25 vs. the industry median of 90.38, Guangxi Wuzhou Zhongheng Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangxi Wuzhou Zhongheng Group Co's current Days Payable of 218.49 is 141.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Guangxi Wuzhou Zhongheng Group Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangxi Wuzhou Zhongheng Group Co's current Days Payable is 218.49, which is 18% above median its own 10-year median of 185.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangxi Wuzhou Zhongheng Group Co stock overvalued right now?
Based on GuruFocus' analysis, Guangxi Wuzhou Zhongheng Group Co (SHSE:600252) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥1.57, compared to a current price of ¥2.15 — trading 36.9% above its estimated fair value. The current Days Payable is 218.49, which is 18% above median its 10-year median of 185.25 and 141.7% above the Drug Manufacturers industry median of 90.38. Guangxi Wuzhou Zhongheng Group Co's overall GF Score™ is 39/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Guangxi Wuzhou Zhongheng Group Co (SHSE:600252), the current Days Payable is 218.49 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guangxi Wuzhou Zhongheng Group Co (SHSE:600252) Overvalued in 2026?
Based on GuruFocus' analysis, Guangxi Wuzhou Zhongheng Group Co stock appears to be overvalued.
The current stock price of ¥2.15 is trading 36.9% above its estimated GF Value™ of ¥1.57.
GuruFocus considers Guangxi Wuzhou Zhongheng Group Co to be Significantly Overvalued.
Key valuation signals for SHSE:600252:
Days Payable: 218.49 (18% above median its 10-year median of 185.25)
GF Value™: ¥1.57 vs. price of ¥2.15 (36.9% above fair value)
Industry Position: 141.7% above the Drug Manufacturers median (#139 of 927)
No single metric tells the full story. See the SHSE:600252 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guangxi Wuzhou Zhongheng Group Co Business Description
Guangxi Wuzhou Zhongheng Group Co Ltd is a Chinese company engaged in the production of Chinese medicines. The company is also involved in real estate and health foods.
39GF Score
Get the complete analysis for SHSE:600252
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600252 has been successfully added to your 
